Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,217 total articles
Virco MFG CORPORATION (NASDAQ:VIRC) Executive Vice President Douglas A. Virtue bought 16,027 shares in two trades on April 14-15, 2026, paying between $6.07 and $6.09 per share for a total outlay of $97,517. The purchases bring his direct holdings to 877,866 shares. The stock trades at $6.09 with a market capitalization of $95.91 million and is ide…
David Spector, Chairman and CEO of PennyMac Financial Services (PFSI), sold 10,000 shares on April 14, 2026 under a prearranged Rule 10b5-1 plan, generating roughly $928,279. The transactions leave Spector with both indirect and direct holdings in the company, including restricted stock units. The sale occurs against a backdrop of a 30% year-to-dat…
Cytokinetics Inc (NASDAQ:CYTK) President and CEO Robert I. Blum sold 7,500 shares on April 15, 2026, for $65.38 per share, a transaction totaling $490,349. After the sale, Blum directly holds 415,330 shares; he also retains indirect holdings through two irrevocable trusts. The sale coincides with CYTK trading close to its 52-week high and a string …
Globalstar Vice President and Chief Financial Officer Rebecca Clary sold 4,037 shares of the company on April 15, 2026, for about $322,354. The sale followed the vesting on April 14 of a performance share award that delivered 9,524 voting common shares with a reported value of $0. After these moves Clary directly holds 115,741 Globalstar shares. Se…
Cytokinetics Executive Vice President and Chief Commercial Officer Andrew Callos sold 7,449 shares of common stock on April 15, 2026, for $66.02 per share, realizing $491,782. The transaction occurred near the stock's 52-week high and follows strong analyst endorsements tied to the Myqorzo (aficamten) program and the upcoming Phase 3 ACACIA trial.
Conagra Brands director Lenny Richard H purchased 25,000 shares on April 14, 2026, for $14.34 per share, totaling $358,500. The trade comes as the stock trades close to its 52-week low and after the company announced a CEO transition. Analysts have responded with divergent ratings and price targets; the company also offers a substantial dividend yi…
RA Capital Healthcare Fund LP disposed of 740,789 shares of Vor Biopharma Inc (NASDAQ:VOR) common stock across three days in mid-April, realizing roughly $11.8 million. After the trades, the fund retains 3,197,619 shares. The stock has fallen about 47% over six months even as the company progresses a Phase 3 Sjögren’s disease trial and receives mul…
Conagra Brands director John J. Mulligan purchased 17,500 shares on April 14, 2026, investing $250,402 at $14.3087 per share. The transaction occurred while the stock sits close to its 52-week low and amid an announced CEO succession. Analysts have responded with fresh coverage and target updates, underscoring questions about valuation as the compa…
Rambus INC director Rao Meera sold 8,538 shares on April 14, 2026, for $118.08 per share, totaling $1,008,167. The transaction was made under a Rule 10b5-1 trading plan adopted November 14, 2025. The company recently reported Q4 2025 EPS in line with expectations and slightly beat revenue, introduced HBM4E Memory Controller IP, and disclosed a CFO …
Heath Tarbert, president of Circle Internet Group, sold 14,900 shares of Class A common stock on April 13, 2026, in a series of trades that generated roughly $1.42 million. The transactions were carried out under a 10b5-1 trading plan. Circle has also rolled out a managed stablecoin settlement product while analysts remain divided on the company's …
Didier Wimmers, Executive Vice President of R&D at Aehr Test Systems, executed two insider sales totaling 5,400 shares and $385,731 in mid-April 2026. The trades occurred as AEHR stock traded close to a 52-week high after a year of strong gains and record quarterly bookings, while the company reported mixed fiscal third-quarter results.
Disc Medicine (NASDAQ: IRON) Chief Medical Officer William Jacob Savage sold 5,731 shares of common stock on April 13, 2026 under a Rule 10b5-1 trading plan, generating about $380,448 in proceeds. The disposal occurred in two tranches and leaves Savage with 79,480 shares directly held. The company, whose shares have climbed more than 70% in the pas…
Village Super Market Inc. Executive Vice President and Secretary John Sumas sold 12,703 Class A shares on April 14, 2026, for a total of $524,672. The sale occurred at prices between $40.945 and $41.87. After the transaction Sumas retains 102,938 shares. The stock is trading at $41.22, with solid gains over recent periods and valuation metrics show…
JPMorgan Chase & Co. Chairman and CEO James Dimon sold 130,488 shares of common stock on April 15, 2026, generating about $40.0 million. The transaction leaves him with substantial direct and indirect holdings. The bank is also close to completing a $38 billion loan syndication for Oracle data center projects, testing Anthropic's Mythos AI, and not…
Marshall Fordyce, President and CEO of Vera Therapeutics, sold 22,951 shares of Class A common stock on April 14, 2026, in transactions executed under a pre-arranged 10b5-1 plan adopted January 9, 2026. The sales totaled $1,011,050 across multiple price points. The company has attracted recent analyst attention and made executive and board appointm…
Bryan Ganz, former President, CEO and Director of Byrna Technologies Inc (BYRN), purchased 1,500 shares on April 15, 2026, at an average price of $6.56 per share for a total of $9,840. The transaction occurred amid substantial stock weakness and after the company reported Q1 2026 earnings and revenue below expectations. Byrna also promoted Matthew …
Disc Medicine Chief Financial Officer Jean M. Franchi executed sales of 6,657 shares of the company's common stock on April 13 and 14, 2026, generating roughly $460,834. The trades were completed under a Rule 10b5-1 plan adopted in September 2025. Meanwhile, the company reported full enrollment in its Phase 3 APOLLO trial for bitopertin, expanded t…
Aehr Test Systems Chief Technology Officer Donald P. Richmond II sold 17,011 shares on April 14, 2026, generating $1.24 million. The transaction occurred while AEHR stock trades close to its 52-week peak amid a dramatic 12-month rally. The company reported mixed Q3 2026 results with an EPS beat, a revenue miss, but record quarterly bookings and an …
Mat Ishbia and SFS Holding Corp sold a combined 2,001,148 shares of UWM Holdings Class A stock on April 14-15, 2026, generating roughly $7.49 million. The trades - completed at prices between $3.71 and $3.78 - occurred while UWMC shares traded near $3.81, down 27% over six months and 47% from the 52-week high. SFS also converted paired interests in…
Jana Partners Management, LP purchased 150,000 shares of Lamb Weston Holdings Inc (NYSE: LW) common stock in two transactions totaling about $6.3 million, according to a Form 4 filing. The purchases occurred on April 13 and April 15, 2026, at prices between $42.12 and $43.19. The move comes as Lamb Weston reported a stronger-than-expected third-qua…
Kopin Corp CEO Michael Andrew Murray sold 187,920 shares on April 13, 2026, for $526,176 under a Rule 10b5-1 trading plan. The company also reported Q4 2025 revenue that missed estimates, with analysts citing a government shutdown that delayed procurement. Craig-Hallum reiterated a Buy rating, highlighting partnerships and potential defense spendin…
FormFactor Inc. CEO Mike Slessor sold 11,204 shares on April 15, 2026, through an automatic Rule 10b5-1 plan, generating roughly $1.44 million in proceeds. The stock is trading near its 52-week high after the company reported fourth-quarter 2025 earnings and revenue that exceeded analyst estimates; one brokerage raised its price target while noting…
Director Ned S. Holmes sold 1,103 shares of Prosperity Bancshares Inc. (NYSE: PB) on April 15, 2026, generating roughly $75,590 in proceeds. The trades executed across a range of prices while the stock trades near $69.12; the company carries a market capitalization of $7.03 billion and a P/E of 12.11. Recent quarterly results showed a small earning…
Mari Steinmetz, Kohl’s senior executive and chief people officer, executed automatic transactions on April 15, 2026 under a Rule 10b5-1 plan that included a small open-market sale and a tax-withholding disposition, while also acquiring shares. The moves occur amid recent quarterly results that topped EPS expectations but missed revenue forecasts an…
Zoom Communications Chief Executive Officer Eric S. Yuan sold $6.9 million worth of Class A Common Stock across multiple transactions on April 13 and 14, 2026, at prices between $79.9468 and $84.3032. The filings show several discrete sales on both days and a conversion of 85,196 Class B shares into Class A shares. Following the transactions, Yuan …
